Circadian rhythm entrainment with melatonin, melatonin receptor antagonist S22153 or their combination in mice exposed to constant light

Journal of Pineal Research

Volumn 37, Issue 3, 2004, Pages 176-184

  Li, X M ^a,c   Beau, J ^a   Delagrange, P ^b   Mocaer E ^b   Levi F ^a  

^a INSERM   (France)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

^c HÔPITAL PAUL BROUSSE   (France)

Author keywords

Antagonist; Body temperature; Circadian rhythms; Continuous light; Locomotor activity; Melatonin; Mice

Indexed keywords

HORMONE RECEPTOR BLOCKING AGENT; MELATONIN; MELATONIN RECEPTOR BLOCKING AGENT; S 22153; UNCLASSIFIED DRUG;

ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; LIGHT; LOCOMOTION; MALE; MOUSE; NONHUMAN; SPECTROSCOPY; TEMPERATURE;

ANIMALS; BODY TEMPERATURE; CIRCADIAN RHYTHM; DRUG THERAPY, COMBINATION; INJECTIONS, INTRAPERITONEAL; LIGHT; MALE; MELATONIN; MICE; MICE, INBRED STRAINS; MOTOR ACTIVITY; RECEPTORS, MELATONIN; THIOPHENES;

EID: 4644275718     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2004.00152.x     Document Type: Article

References (41)

1. RUSAK B, ZUCKER I. Neural regulation of circadian rhythms. Physiol Rev 1979; 59:449-526.
2. DEPRÉS-BRUMMER P, BOURIN P, PAGES N et al. Persistent T lymphocyte rhythms despite suppressed circadian clock outputs in rats. Am J Physiol 1997; 273:R1891-R1899.
3. DEPRÉS-BRUMMER P, METZGER G, LÉVI F. Pharmacological restoration of suppressed temperature rhythms in rats by melatonin, melatonin receptor agonist, S20242, or 8-OH-DPAT. Eur J Pharmacol 1998; 347:57-66.
4. BENLOUCIF S, MASANA MI, DUBOCOVICH ML. Responsiveness to melatonin and its receptor expression in the aging circadian clock of mice. Am J Physiol 1997; 273:R1855-R1860.
5. GOTO M, OSHIMA I, TOMITA T et al. Melatonin content of the pineal gland in different mouse strains. J Pineal Res 1989; 7:195-204.
6. MURAKAMI N, MARUMOTO N, NAKAHARA K et al. Daily injection of melatonin entrain the circadian activity rhythms of nocturnal rats but not diurnal chipmunks. Brain Res 1997; 775:240-243.
7. PITROSKY B, KIRSCH R, MALAN A et al. Organization of rat circadian rhythms during daily infusion of melatonin or S20098, a melatonin agonist. Am J Physiol 1999; 277:R812-R828.
8. VIVIEN-ROELS B, MALAN A, RETTORI MC et al. Daily variations in pineal melatonin concentrations in inbred and outbred mice. J Biol Rhythms 1998; 13:403-409.
9. CANTI A, MAESTRONI GJ. HPLC validation of a circadian melatonin rhythm in the pineal gland of inbred mice. J Pineal Res 1996; 20:138-144.
10. LI XM, LIU XH, FILIPSKI E et al. Relationship of atypical melatonin rhythm with two circadian clock outputs in B6D2F1 mice. Am J Physiol 2000; 278:R924-R930.
11. ROSEBOOM P, NAMBOODIRI MAA, ZIMONJIC DB et al. Natural melatonin 'knockdown' in C57BL/6J mice: rare mechanism truncates serotonin N-acetyltransferase. Mol Brain Res 1998; 63:189-197.
12. DE LEERSNYDER H, DE BLOIS MC, CLAUSTRAT B et al. Inversion of the circadian rhythm of melatonin in the Smith-Magenis syndrome. J Pediatr 2001; 139:111-116.
13. 2 receptors. Naunyn Schmiedebergs Arch Pharmacol 2003; 367:553-561.
14. DELAGRANGE P, TING KN, KOPP C et al. In vitro and in vivo antagonist properties of S22153, a new melatonin ligand. Fundam Clin Pharmacol 1999; 13:253 Abstr.
15. WEIBEL L, RETTORI MC, LESIEUR D et al. A single oral dose of S22153, a melatonin antagonist, blocks the phase advancing effects of melatonin in C3H mice. Brain Res 1999; 829:160-166.
16. KOPP C, VOGEL E, RETTORI MC et al. Regulation of emotional behaviour by day length in mice: implication of melatonin. Behav Pharmacol 1999; 10:747-752.
17. VAN DEN HEILIGENBERG S, DEPRÉS-BRUMMER P, BARBASON H et al. The tumor promoting effect of constant light exposure on diethylnitrosamine-induced hepatocarcinogenesis in rats. Life Sci 1999; 64:2523-2534.
18. HALBERG F, CARANDENTE F, CORNELISSEN G et al. Glossary of chronobiology. Chronobiologia 1977; 4(Suppl. 1):1-189.
19. DE PRINS J, CORNELISSEN G, MALBECQ W. Statistical procedures in chronobiology and chronopharmacology. Ann Rev Chronopharmacol 1986; 2:27-141.
20. SFAKSI N, METZGER G, FILIPSKI E et al. Circadian system alteration in mice by constant light or darkness exposure. Chronobiol Int 1997; 14(Suppl. 1):311.
21. ASCHOFF J. Exogenous and endogenous components in circadian rhythms. Cold Spring Harbor Symp Quant Biol 1960; 25:11-28.
22. HARUMI T, MATSUSHIMA S. Indoleamine metabolism in the pineal gland the Chinese hamsters, Cricetulus griseus. Gen Comp Endocrinol 1998; 109:133-139.
23. REDMAN JR, ARMSTRONG SM, NG KT. Free-running activity rhythms in the rats: entrainment by melatonin. Science 1983; 219:1089-1091.
24. KOPP C, VOGEL E, RETTORI MC et al. The effects of melatonin on the behavioral disturbances induced by chronic mild stress in C3H/He mice. Behav Pharmacol 1999; 10:73-83.
25. SLOTTEN H, PITROSKY B, PÉVET P. Influence of the mode of daily melatonin administration on entrainment of rat circadian rhythms. J Biol Rhythms 1999; 14:347-353.
26. WARREN WS, HODGES DB, CASSONE VM. Pinealectomized rats entrain and phase-shift to melatonin injections in a dose dependent manner. J Biol Rhythms 1993; 8:233-245.
27. LEWY AJ, BAUER VK, AHMED S et al. The human phase response curve (PRC) to melatonin is about 12 hours out of phase with the PRC to light. Chronobiol Int 1998; 15:71-83.
28. SACK RL, BRANDES RW, KENDALL AR et al. Entrainment of free-running circadian rhythms by melatonin in blind people. N Engl J Med 2000; 343:1070-1077.
29. SIUCIAK JA, FANG JM, DUBOCOVICH ML. Autoradiographic localization of 2-[125I]iodomelatonin binding sites in the brains of C3H/HeN and C57BL/6J strains of mice. Eur J Pharmacol 1990; 180:387-390.
30. MORGAN PJ, BARRETT P, HOWELL HE et al. Melatonin receptors: localization, molecular pharmacology and physiological significance. Neurochem Int 1994; 24:101-146.
31. GAUER F, MASSON-PÉVET J, STEHLE P et al. Daily variations in melatonin receptor density of rat pars tuberalis and suprachiasmatic nuclei; evidence for a regulation of melatonin receptors by melatonin itself. Brain Res 1994; 641:92-98.
32. KOPP C, VOGEL E, RETTORI MC et al. Reentrainment of the spontaneous locomotor activity rhythm to a daylight reversal in C57BL/6 and C3H/He mice: implication of melatonin. Physiol Behav 2000; 70:171-176.
33. YING SW, DELAGRANGE P, RUSAK B. Neurophysiological studies of a novel melatonin receptor antagonist in the rat suprachiasmatic nucleus (SCN). Soc Neurosci 1999; 25:531 Abstr 140.9.
34. LIU C, WEAVER DR, JIN X et al. Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron 1997 19:91-102.
35. DUBOCOVICH ML, YUN K, AL-GHOUL WM et al. Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms. FASEB J 1998; 12:1211-1220.
36. JIN X, VON GALL C, PIESCHL RL et al. Targeted disruption of the mouse Mellb melatonin receptor. Mol Cell Biol 2003; 23:1054-1060.
37. DUBOCOVICH ML, MASANA MI, SUMAYA IC et al. Effect of MT1 melatonin receptor deletion on melatonin-mediated phase shift of circadian rhythms of locomotor activity in the C57B6 mouse. Soc Neurosci CD-ROM (2003); Abstr 512.3.
38. REDMAN J, ARMSTRONG SM, NG KT. Free-running activity rhythms in the rat: entrainment by melatonin. Science 1983; 219:1089-1091.
39. CHESWORTH MJ, CASSONE VM, ARMSTRONG SM. Effects of daily melatonin injections on activity rhythms of rats in constant light. Am J Physiol 1987; 253:R101-R107.
40. GOLDBETER A, CLAUDE D. Time-patterned drug administration: insights from a modeling approach. Chronobiol Int 2002; 19:157-177.
41. LELOUP JC, GOLDBETER A. Toward a detailed computational model for the mammalian circadian clock. Proc Natl Acad Sci USA 2003; 10:7051-7056.